Oncology
Product Description
Biophore Pharma INC.
-
Country/Region:United States
-
On CPHI since:2015
-
Certificates:3
Company types
Biophore Pharma INC.
-
Country/Region:United States
-
On CPHI since:2015
-
Certificates:3
Company types
More Products from Biophore Pharma INC. (62)
-
Product Trifluridine
Trifluridine is an Antiviral agent indicated for the treatment of of primary kerato conjunctivitis and recurrent epithelial keratitis. -
Product DOTA
DOTA is an Chelating agent
Biophore's DOTA: All impurities below 0.07 (% w/w), Stringent control on sodium and chloride, Stable at room temperature, Commercialized product for Europe. -
Product DTPA
DTPA is an Chelating agent
Biophore's DTPA: Stringent control on Iron content, All impurities below 0.01 -
Product Trientine
Trientinen is indicated for the treatment of patients with Wilson's disease who are intolerant of penicillamine.
Biophore's Trientine: DMF Filed
-
Product Cannabidiol API (CBD)
Ultrapure synthetic cannabidiol with US DMF -
Product Aviptadil
Aviptadil -
Product Benserazide
Benserazide -
Product Carfilzomib
Carfilzomib -
Product Cladribine
Cladribine
-
Product Cyclen
Cyclen -
Product Development and manufacture of pharmaceutical actives
Biophore pharma inc offers services which includes development and manufacture of pharmaceutical actives. Features: it is used for oncology medications, contrast and diagnostic media. Contact us for more information.
Biophore Pharma INC. resources (2)
-
Video Biophore India Pharmaceuticals Pvt Ltd. at CPHI BCN 2023
Biophore India Pharmaceuticals Pvt Ltd. at CPHI BCN 2023 -
Video BioPhore India Pharmaceuticals Pvt Ltd at CPHI Worldwide 2018
Dr. Jagadeesh Babu Ranglsetty, Founder & CEO of BioPhore India Pharmaceuticals Pvt. Ltd., speaks With CPHI TV at CPHI Worldwide in Madrid, Spain




